Skip to content
+49 3371 6199600info@celltrend.deIm Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Contact
  • German
  • English
topbar - English
Search:
Suche
CellTrend Luckenwalde
Auftragsforschung, Antikörperdiagnostik
CellTrend LuckenwaldeCellTrend Luckenwalde
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS–CFS/ME–SFN-Long Covid
    • Information for patients
  • AT1R-Antibody ELISA
    • Product information
    • Transplantation
    • Systemic sclerosis
    • Literature
  • ELISA
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS–CFS/ME–SFN-Long Covid
    • Information for patients
  • AT1R-Antibody ELISA
    • Product information
    • Transplantation
    • Systemic sclerosis
    • Literature
  • ELISA
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research

Daily Archives: 10. December 2018

You are here:
  1. Home
  2. 2018
  3. December
  4. 10

Our latest publication in Nature Communication

NewsBy celltrend celltrend10. December 2018

Have a look at our latest publication in Nature Communication about autoantibodies against GPCR! 2018 Naturecommunication https://www.nature.com/articles/s41467-018-07598-9

+49 3371 6199600 info@celltrend.de Im Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Data protection declaration
  • Imprint
bottombar - English

FacebookInstagram

Go to Top